1. Home
  2. LGND vs WSC Comparison

LGND vs WSC Comparison

Compare LGND & WSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • WSC
  • Stock Information
  • Founded
  • LGND 1987
  • WSC 1944
  • Country
  • LGND United States
  • WSC United States
  • Employees
  • LGND 68
  • WSC N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • WSC Misc Corporate Leasing Services
  • Sector
  • LGND Health Care
  • WSC Industrials
  • Exchange
  • LGND Nasdaq
  • WSC Nasdaq
  • Market Cap
  • LGND 3.2B
  • WSC 3.8B
  • IPO Year
  • LGND 1992
  • WSC N/A
  • Fundamental
  • Price
  • LGND $191.31
  • WSC $21.75
  • Analyst Decision
  • LGND Strong Buy
  • WSC Buy
  • Analyst Count
  • LGND 8
  • WSC 9
  • Target Price
  • LGND $144.71
  • WSC $30.38
  • AVG Volume (30 Days)
  • LGND 139.7K
  • WSC 2.1M
  • Earning Date
  • LGND 08-05-2025
  • WSC 11-06-2025
  • Dividend Yield
  • LGND N/A
  • WSC 1.29%
  • EPS Growth
  • LGND N/A
  • WSC N/A
  • EPS
  • LGND N/A
  • WSC 0.59
  • Revenue
  • LGND $181,488,000.00
  • WSC $2,352,581,000.00
  • Revenue This Year
  • LGND $18.41
  • WSC N/A
  • Revenue Next Year
  • LGND $18.87
  • WSC $2.83
  • P/E Ratio
  • LGND N/A
  • WSC $37.08
  • Revenue Growth
  • LGND 53.40
  • WSC N/A
  • 52 Week Low
  • LGND $81.74
  • WSC $20.08
  • 52 Week High
  • LGND $129.90
  • WSC $42.15
  • Technical
  • Relative Strength Index (RSI)
  • LGND 66.71
  • WSC 45.43
  • Support Level
  • LGND $182.87
  • WSC $21.31
  • Resistance Level
  • LGND $194.44
  • WSC $23.07
  • Average True Range (ATR)
  • LGND 5.79
  • WSC 0.84
  • MACD
  • LGND -0.38
  • WSC 0.08
  • Stochastic Oscillator
  • LGND 81.23
  • WSC 32.99

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About WSC WillScot Mobile Mini Holdings Corp.

WillScot Holdings Corp designs, delivers, and services onsite, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company includes modular office complexes, mobile offices, portable storage containers, and others.

Share on Social Networks: